224 related articles for article (PubMed ID: 35303269)
1. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
Capdevila J; Gómez MA; Guillot M; Páez D; Pericay C; Safont MJ; Tarazona N; Vera R; Vidal J; Sastre J
Clin Transl Oncol; 2022 Apr; 24(4):646-657. PubMed ID: 35303269
[TBL] [Abstract][Full Text] [Related]
2. Latest evidence on the management of early-stage and locally advanced rectal cancer: a narrative review.
Prabhakaran S; Yang TWW; Johnson N; Bell S; Chin M; Simpson P; Carne P; Farmer C; Skinner S; Warrier SK; Kong JC
ANZ J Surg; 2022 Mar; 92(3):365-372. PubMed ID: 35001464
[TBL] [Abstract][Full Text] [Related]
3. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
4. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Li Y; Wang J; Ma X; Tan L; Yan Y; Xue C; Hui B; Liu R; Ma H; Ren J
Int J Biol Sci; 2016; 12(8):1022-31. PubMed ID: 27489505
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
6. Evolution of therapy for locally advanced rectal cancer.
Altomare NJ; Mulcahy MF
J Surg Oncol; 2024 Jan; 129(1):78-84. PubMed ID: 38063061
[TBL] [Abstract][Full Text] [Related]
7. Current status of locally advanced rectal cancer therapy and future prospects.
Koukourakis IM; Kouloulias V; Tiniakos D; Georgakopoulos I; Zygogianni A
Crit Rev Oncol Hematol; 2023 Jun; 186():103992. PubMed ID: 37059276
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
[No Abstract] [Full Text] [Related]
9. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
10. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
Fan J; Zhu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial.
Wang J; Fan J; Li C; Yang L; Wan J; Zhang H; Zhang Z; Zhu J
Clin Colorectal Cancer; 2020 Jun; 19(2):e58-e69. PubMed ID: 32265117
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
13. Curative therapy for rectal cancer.
Alawawdeh A; Krishnan T; Roy A; Karapetis C; Joshi R; Singhal N; Price T
Expert Rev Anticancer Ther; 2021 Feb; 21(2):193-203. PubMed ID: 33161803
[No Abstract] [Full Text] [Related]
14. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
Ozer L; Yildiz I; Bayoglu V; Bozkurt M; Esen E; Remzi FH; Gogenur I; Aytac E
Colorectal Dis; 2021 Jul; 23(7):1662-1669. PubMed ID: 33829626
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
16. Management of Locoregional Rectal Cancer.
Willett CG
J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
[TBL] [Abstract][Full Text] [Related]
17. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant radiotherapy for rectal cancer management.
Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
[TBL] [Abstract][Full Text] [Related]
19. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
